Crossmark

Concurrent miR-21 suppression and FXR activation as a mechanism of improvement in nonalcoholic fatty liver disease

Published Online: 2018-03-02

Authors

Mazzini, Guilherme S.

Khoraki, Jad

Browning, Matthew G.

Campos, Guilherme M.
License Information

Text and Data Mining valid from 2018-03-02

Version of Record valid from 2018-03-02
More Information

Article History

Received: 6 December 2017

Revised: 29 January 2018

Accepted: 30 January 2018

First Online: 2 March 2018

Conflict of interest

: The authors declare that they have no conflict of interest.

Document is current